BIOREM Inc.
BRM.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -92.98% | 145.57% | 56.12% | 1,978.38% | -78.77% |
| Total Depreciation and Amortization | -3.82% | -29.21% | 21.93% | -15.80% | -6.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 202.64% | -123.66% | 30.60% | 361.39% | 112.04% |
| Change in Net Operating Assets | -401.65% | 161.97% | 67.71% | -158.55% | 407.22% |
| Cash from Operations | -133.51% | 270.24% | 167.77% | -129.52% | 370.99% |
| Capital Expenditure | -865.84% | -10,200.00% | 100.11% | -184.36% | -1,610.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -865.84% | -10,200.00% | 100.11% | -184.36% | -1,610.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -27.75% | -0.76% | 22.98% | 9.22% | -59.03% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.44% | 47.55% | -31.14% | 5.85% | -836.41% |
| Foreign Exchange rate Adjustments | 208.92% | -275.09% | 121.59% | -1,561.33% | 97.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.13% | 348.72% | 135.88% | -145.98% | 307.55% |